Karen Chu

Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States

grad student

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Herrejon Chavez F, Luo H, Cifani P, et al. (2023) RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells. Nature Communications. 14: 2290
Erazo T, Evans CM, Zakheim D, et al. (2022) TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma. Nature Communications. 13: 5676
Cheng Y, Xie W, Pickering BF, et al. (2021) N-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation. Cancer Cell
Nguyen DTT, Lu Y, Chu KL, et al. (2020) HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells. Nature Communications. 11: 2026